Senté Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Series G
- Investors
-
1
Senté General Information
Description
Developer of skin care products designed to deliver novel, science-based beauty goods. The company's products offer a formulation of active ingredients that help in cell renewal, new collagen development, skin hydration and gradually lightening the appearance of pigmented lesions, enabling customers to achieve younger-looking and healthier skin.
Contact Information
Website
www.sentelabs.comCorporate Office
- 701 Palomar Airport Road
- Suite 300
- Carlsbad, CA 92011
- United States
Corporate Office
- 701 Palomar Airport Road
- Suite 300
- Carlsbad, CA 92011
- United States
Senté Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series G) | 16-Apr-2026 | Completed | Generating Revenue | |||
| 9. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 8. Debt - General | 27-Sep-2018 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series F) | 22-Jun-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series E) | 08-Sep-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 07-Jun-2017 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 02-Jun-2014 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 14-May-2013 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 15-Apr-2011 | $847K | $1.55M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 31-Jan-2009 | $698K | $698K | Completed | Generating Revenue |
Senté Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 3,360,000 | $0.001000 | 8% | $0.62 | $0.62 | 1x | $0.62 | 5.06% |
| Series A | 3,090,838 | $0.001000 | 8% | $0.5 | $0.5 | 1x | $0.5 | 4.65% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Senté Comparisons
Industry
Financing
Details
Senté Competitors (1)
One of Senté’s competitors is Cyspera, a Private Equity-Backed company based in Geneva, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cyspera | Private Equity-Backed | Geneva, Switzerland |
Senté Patents
Senté Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-6151568-A | Power estimation software system | Inactive | 13-Sep-1996 |
Senté Signals
Senté Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ALMA Life Sciences | Venture Capital | Minority |
Senté FAQs
-
When was Senté founded?
Senté was founded in 2007.
-
Where is Senté headquartered?
Senté is headquartered in Carlsbad, CA.
-
What is the size of Senté?
Senté has 45 total employees.
-
What industry is Senté in?
Senté’s primary industry is Personal Products.
-
Is Senté a private or public company?
Senté is a Private company.
-
What is Senté’s current revenue?
The current revenue for Senté is .
-
How much funding has Senté raised over time?
Senté has raised $38.6M.
-
Who are Senté’s investors?
ALMA Life Sciences has invested in Senté.
-
Who are Senté’s competitors?
Cyspera is a competitor of Senté.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process